期刊文献+

曲伏前列素滴眼液治疗难治性青光眼的临床研究 被引量:2

Clinical study of Travoprost(Travatan) in treating patients with refractory glaucoma
下载PDF
导出
摘要 目的探讨曲伏前列素滴眼液(苏为坦)治疗难治性青光眼的疗效及安全性。方法难治性青光眼20例(20只眼),所有患眼均经1次以上手术未能有效控制眼压。对上述患者单独应用曲伏前列素滴眼液,每晚1次。用药后1个月及6个月在同一时段复查眼压1次,用药6个月后在同1天的8、11、14、16点钟分别检查眼压。观察用药前后的眼压、眼底及视野情况。结果用药前眼压24~33mmHg,平均27.8mmHg,用药1个月后眼压16~24mmHg,平均18.6mmHg,用药6个月后眼压15~25mmHg,平均18.3mmHg,治疗6个月后不同时间点眼压变化值比较差异无统计学意义(P>0.05)。眼底、视神经及视野未见明显进展。结膜充血是最常见副作用,见于本组所有眼。但仅3只眼达3级,其余均为1~2级,并随时间延长减轻。2只眼出现眼周皮下色素沉着,2只眼睫毛长长。未发现严重副作用,所有患者均未因副作用停药。结论曲伏前列素滴眼液能安全有效的降低难治性青光眼的眼压,其降眼压效果可靠,使用方便,患者依从性好,副作用小。 Obeject To evaluate the clinical effect and side effect of travoprost in treating patients with refractory glaucoma. Methods The eases were 20 eyes of 20 patients with refractory glaucoma. All eyes had at least one surgery and fail to control IOL. All patients with travoprost one drop at night once daily were studied. The observed signs included lOP (measured at the same time on the one and six month, and 8:00,11:00,14:00,16:00 at one day on six month), visual acuity, visual field and complications. Results The IOP was 27.8 mm Hg before using travoprest (from 24 to 33 nan Hg), One month after treatmem, the lOP was 18.6 mm Hg( from 16 to 24 mm Hg ). The last lOP was 18.3 mm Hg( from 15 to 25 mm Hg), After 6 months, IOP reductions had no obvious difference when measured at different time on the same day ( P 〉0.05 ) . There were no change of visual acuity ,optic nerve and visual field before and after using travoprost. All eases appeared conjunetival congestion, but they were 1-2 grade besides of 3 eyes were 3 grade, and all eyes eased with the extension of time, furthermore, 2 eyes had pigmentation on preorbit. Eyelashes of 2 eyes becoming rougher and longer. Except above described symptom , no other advere reaction both local and systemic were observed, and no eases interrupted the treatment because of the Side Effects. Conclusion It is demonstrated that travoprest is effective and safe in reducing IOP in refractory glaucoma. It is reliable and easy to use, and in the meanwhile, it had good patients compliance and small side effects.
出处 《临床眼科杂志》 2009年第5期427-429,共3页 Journal of Clinical Ophthalmology
关键词 曲伏前列素 苏为坦 青光眼 眼压 Travoprost Travatan Glaucoma Intraocular pressure
  • 相关文献

参考文献13

  • 1徐力,陆蓓.青光眼神经保护治疗研究进展[J].眼科新进展,2004,24(6):494-497. 被引量:9
  • 2Netland PA, Landry T, Sullivan EK, et al. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hyper tenfion. Am J Ophthalmol,2001,132 :472. 被引量:1
  • 3Parrish RK, Palmberg P, Sheu WP , et al. A comparison of Latanoprost, bimatoprost and travoprost in patients with elevated intraocular pressure :A 12-week, randomized, masked evaluator, multicenter study. Am J Ophthalmol,2003 ,135 :688. 被引量:1
  • 4孙兴怀.难治性青光眼的治疗[J].国外医学(眼科学分册),1995,19(1):26-31. 被引量:201
  • 5崔露阳.曲伏前列素:有效的降眼压剂[J].世界临床药物,2004,25(10):634-635. 被引量:3
  • 6Stjems ehantz JW. From PGF ( -alpha ) -isopropyl ester to latanoprost : a review of the development of xalatan: the proetor lecture. Invest Ophthalmol Vis Sci ,2001,42 : 1134-1145. 被引量:1
  • 7Aung T,Chan YH,Chew PT,EXACT Study Group. Degree of angle closu re and the intraocular pressure lowering effect flatanoprost in subjects with chronic angle-closure glaucoma. Ophthalmology, 2005,112: 267-271. 被引量:1
  • 8Romant J P, Maurent Palombi K, NoAl C. N yetohemera variations in intraoeular pressure. J Fr Ophthalmol,2004,27 : 19-26. 被引量:1
  • 9Zeimer RC,Wilensky JT,Gieser DK,et al. Association between intraocular pressure peaks and progression of visual field loss. Ophthalmology, 1991,98:64. 被引量:1
  • 10Goldberg I, Cunha Vaz J , Jak obsen J E, et al. Comparison of topical travoprvet eye drops given once daily and timolol 0. 5% given twice daily in patients with open angle glaucom aor ocular hyper tension. J Glaucoma,2001,10 : 414-422. 被引量:1

二级参考文献42

  • 1Rosenbaum DM, Rosenbaum PS, Singh M, Gupta G, Gupta H,Li B, et al. Functional and morphologic of two methods to produce transient retinal ischemia in the rat [J]. J Neuroophthalmol 2001;21(1) :62-68. 被引量:1
  • 2Tezel G, Wax MB. Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells[J]. JNeurosci 2000;20(23):8693-8700. 被引量:1
  • 3Klocker N,Kermer P, Weishaupt JH, Labes M,Ankerhold R,Bahr M. Brain-derived neurotrophic factor-mediated neuroprotection of adult rat retinal ganglion cells in vivo doses not exclusively depend on phosphatidy inosltol3'-kinase/protein kinase B signaling[J 被引量:1
  • 4Wen R, Cheng T, Li Y, Gao W, Steinberg RH. Alpha-2-adrenergic agonists induce basic fibroblast growth factor expression in photoreceptors in vivo and ameliorate light damage[J]. J Neurosci 1996; 16 ( 19 ): 5986-5992. 被引量:1
  • 5Levkovitch-Verbin H, Quigley HA, Kerrigan-Baumrind LA,D'Anna SA, Kerrigan D, Pesse ME. Optic nerve transaction in monkeys may result in secondary degeneration of retinal ganglion cells[J]. Invest Ophthalmol Vis Sci 2001 ;42(5) :975-982. 被引量:1
  • 6Daugeliene L, Niwa M, Hara A, Matsuno H, Yamamoto T, Kitszawa Y, et al. Transient ischemic injury in the rat retina caused by thrombotic occlusion-thrombolytic reperfusion [J]. Invest Ophthalmol Vis Sci 2000;41(9):2743-2747. 被引量:1
  • 7Hare W,WoldeMussie E, Lai R,Ton H,Ruiz G,Feldmann B,et al. Efficacy and safety of memantine,an NMDA-type openchannel blocker, for reduction of retinal injury associated with experimental glaucoma in rat and monkey [J]. Surv Ophthalmol 2001 ;45(Suppl 3): S 被引量:1
  • 8Levkovitch-Verbin H, Quigley HA, Martin KR, Valenta D,Baumrind LA, Pease ME. Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats [J]. Invest Ophthalmol Vis Sci 2002;43(2) :402-410. 被引量:1
  • 9Donello JE, Padillo EU, Webster ML, Wheeler LA, Gil DW.Alpha (2)-Adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia[J]. J Pharmcol Exp Ther 2000;296(1): 216-223. 被引量:1
  • 10Lafuente MP, Villegas-Perez MP, Sobrado-Calvo P, GarciaAviles A, Miralles de Imperial J, Vidal-Sanz M. Neuroprotective effects of alpha (2)-selective adrenergic agonists against ischemia-induced retinal ganglion cell death[ J]. Invest Ophthalmol Vis Sci 2 被引量:1

共引文献210

同被引文献20

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部